Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 215.00
-6.50 (-2.93%)
Aug 11, 2025, 1:35 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 57.98 billion as of August 8, 2025. Its market cap has decreased by -22.15% in one year.
Market Cap
57.98B
Enterprise Value
64.77B
Revenue
19.12B
Ranking
n/a
PE Ratio
10.69
Stock Price
215.00
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 57.98B, an increase of 531.05%. That is a compound annual growth rate of 18.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 56.15B | -21.50% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | 19.63B | -29.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.81B |
| Center Laboratories | 27.03B |
| Pegavision | 24.80B |
| Lumosa Therapeutics | 23.97B |